Episurf Medical AB (publ) (FRA:16E)

Market Cap	58.55M +1,066.6%
Revenue (ttm)	2.36M +123.1%
Net Income	-26.66M
EPS	-0.00
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,000
Open	0.0001
Previous Close	0.0001
Day's Range	0.0001 - 0.0001
52-Week Range	0.0001 - 0.0210
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 13, 2026

About Episurf Medical AB

Episurf Medical AB (publ), a medical device company, designs and manufactures implants and surgical instruments in Germany, Sweden, rest of Europe, the United States, and internationally. It provides Episealer Knee for repairing focal cartilage and bone defects to reduce pain and increase mobility in the patient’s knee joint; Episealer implant, which is designed to fit anatomy and size of the lesion; Episealer toolkit; and Episealer Patellofemoral System, a system to treat osteoarthritis limited to the patellofemoral part of the knee joint. The...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2008
• Employees: 22
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 16E

Financial Performance

In 2025, Episurf Medical AB's revenue was 13.50 million, an increase of 3.85% compared to the previous year's 13.00 million. Losses were -58.20 million, -23.42% less than in 2024.

Financial numbers in SEK

Data Sources: S&P Global Market Intelligence and Twelve Data

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Twelve Data.

Last checked:

Oct 26, 2026

Data Sources Report a data error